DH
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer | Cellular and molecular life sciences | 2023 | 124 | 295 | |||
| CRISPR-Cas9 screen reveals a role of purine synthesis for estrogen receptor α activity and tamoxifen resistance of breast cancer cells | Science advances | 2023 | 92 | 374 | |||
| Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma | Journal of experimental & clinical cancer research | 2023 | 180 | 86 | |||
| Hsf1 and the molecular chaperone Hsp90 support a ‘rewiring stress response’ leading to an adaptive cell size increase in chronic stress | eLife | 2023 | 101 | 206 | |||
| Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer | Cancers | 2022 | 215 | 332 | |||
| Genetic and multidrug combinatorial screens unravel new mechanistic clues and optimised therapeutics for estrogen receptor alpha-mediated breast cancer | 2022 | 416 | 209 | ||||
| Translational reprogramming in response to accumulating stressors ensures critical threshold levels of Hsp90 for mammalian life | Nature communications | 2022 | 323 | 436 |
